New reporting shows Epstein paid consultants and used fake sites and Wikipedia edits to bury negative search results and burnish a philanthropic image.

Pfizer reported mid‑stage results showing atirmociclib plus fulvestrant cut progression or death risk by about 40% in patients previously treated with CDK4/6 inhibitors.

A viral cellphone clip from Corona shows three glowing orbs moving in a triangular pattern. Authorities say corroborating radar or sensor data are needed to identify the sighting.

UT Austin researchers built a near-atomic map of the Andes hantavirus and produced a vaccine candidate that triggered neutralizing antibodies in mice.

Gracenote sued OpenAI in Manhattan, alleging its curated media metadata was copied to train ChatGPT. The suit says the company's database structure was used without permission.

Federal probes into banks' AI hiring tools raise questions about bias in résumé screeners. Here’s what researchers and regulators are watching and how applicants can respond.

Perplexity asked a federal judge to narrow parts of suits by The New York Times and Chicago Tribune while leaving core copyright allegations intact.

Trump Media said it is in talks to spin off Truth Social and merge the platform with a SPAC after its planned merger with fusion firm TAE Technologies.

A small NYU Langone pilot found microplastic fragments in nine of 10 prostate tumors, with tumor tissue holding roughly 2.5 times more plastic than nearby healthy tissue. Researchers call the result surprising but preliminary.

Mount Sinai is rolling out face‑scan check‑ins with CLEAR1 across its hospitals and clinics, promising faster check‑ins and fewer duplicate records while prompting privacy debate.

Hong Kong’s RedotPay is reportedly weighing a New York IPO that could raise more than $1 billion and value the company north of $4 billion as regulators ready licenses. Investors will be watching reserves and redemption rules closely.

Mount Sinai‑affiliated clinics in Manhattan are using an FDA‑cleared AI from BrightHeart to flag fetal heart abnormalities, a move studies show boosts detection and shortens review time.

Nobel laureate Richard Axel stepped down as co‑director of Columbia’s Zuckerman Institute after DOJ records linked him to Jeffrey Epstein. Columbia said it found no evidence of legal violations but accepted his resignation.